Nicola Goekbuget

Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia

Claudia D. Baldus, Julia Thibaut, Nicola Goekbuget et al. · Haematologica · 2009 · 85 citations · Full text

Medicine, Hematology, Oncology +12

Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003

Dieter Hoelzer, Andreas Huettmann, Felix Kaul et al. · Blood · 2010 · 83 citations

Life Sciences, Immunology, Oncology +12

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Nicola Goekbuget, Joachim Beck, Monika Brüggemann et al. · Blood · 2012 · 78 citations

Medicine, Geriatric Medicine, Oncology +14

Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation

Katharina Raum, Sandra Marković, Verena Nowak et al. · Blood · 2018 · 77 citations · Full text

Medicine, Genetics, Molecular Genetics +11

BLAST: A Confirmatory, Single-Arm, Phase 2 Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE®) Antibody Construct, in Patients with Minimal Residual Disease B-Precursor Acute Lymphoblastic Leukemia (ALL)

Nicola Goekbuget, Hervé Dombret, Massimiliano Bonifacio et al. · Blood · 2014 · 59 citations

Medicine, Hematology, Immunology +16